In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)


The Latest

Filters

Optics Outfitter

Ad Alert

Optics Outfitter

Why this eyewear company’s advertised “starting” prices may not be 20/20.


Show More